WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Phase 2
Completed
- Conditions
- Alzheimers Disease, FamilialDementiaAlzheimers Disease
- Interventions
- Drug: Matching Placebo (Gantenerumab)Drug: Matching Placebo (Solanezumab)
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 194
- Registration Number
- NCT04623242
- Locations
- πΊπΈ
University of California San Diego Medical Center, La Jolla, California, United States
πΊπΈWashington University in St. Louis, Saint Louis, Missouri, United States
πΊπΈColumbia University, New York, New York, United States
Using Health Information Technology to Improve Health Behaviors and Promote Cardiovascular Health Among Adolescent and Young Adult Cancer Survivors
Not Applicable
Completed
- Conditions
- Cardiovascular DiseaseYoung Adult Cancer Survivors
- Interventions
- Behavioral: Wait-List ControlBehavioral: PREVENT tool
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 26
- Registration Number
- NCT04623190
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Phase 1
Terminated
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT04624113
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Serum Neurofilament Light (NfL) as a Marker for Brain Injury in Individuals Undergoing Chimeric Antigen Receptor-modified T Therapy
Terminated
- Conditions
- Neurotoxicity
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 17
- Registration Number
- NCT04614987
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)
Phase 2
Active, not recruiting
- Conditions
- RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
- Interventions
- First Posted Date
- 2020-11-02
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT04611880
- Locations
- πΊπΈ
Andria Ford, Saint Louis, Missouri, United States
πΊπΈPerelman School of Medicine; University of Pennsylvania, Philadelphia, Pennsylvania, United States
Tariquidar-ondansetron Combination in Neuropathic Pain
Phase 1
Completed
- Conditions
- Neuropathic Pain
- Interventions
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 23
- Registration Number
- NCT04603066
- Locations
- πΊπΈ
Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT
Not Applicable
Completed
- Conditions
- Adolescent DepressionAnxiety Disorders
- Interventions
- Behavioral: mHealth app
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT04603053
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Aging With Long Term Physical Disabilities
Not Applicable
Completed
- Conditions
- Physical Disability
- Interventions
- Behavioral: Waitlist Attentional ControlBehavioral: Removing Environmental Barriers to Independent Living (REBIL)
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT04589988
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
CCR2 AAA Pilot Study
Early Phase 1
Terminated
- Conditions
- Abdominal Aortic Aneurysm (AAA)
- Interventions
- Diagnostic Test: AAA Group- PET-CT imaging with injection of 64Cu-DOTA-ECL1iDiagnostic Test: Aortoiliac Occlusive Disease Group - PET-CT imaging with injection of 64Cu-DOTA-ECL1i
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2022-04-15
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 1
- Registration Number
- NCT04592991
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Chromosome 9 P Minus Syndrome
Recruiting
- Conditions
- Chromosome 9P Deletion Syndrome9P MonosomyAlfi Syndrome9P Partial Monosomy Syndrome9p Minus Syndrome
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 200
- Registration Number
- NCT04586400
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Β© Copyright 2025. All Rights Reserved by MedPath